Shares of Celldex Therapeutics Inc. (NASDAQ: CLDX), a biopharmaceutical company engaged in the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases, surged in trading on Friday.
[...]
Recent Comments